Integrated transcriptomic analysis and experimental validation identify ACADL as a mitochondrial tumor suppressor via the FOXO3a/PUMA axis in lung adenocarcinoma
ACADL functions as a mitochondria-associated tumor suppressor that impedes LUAD progression through activation of the FOXO3a/PUMA signaling pathway, underscoring its potential as a therapeutic target for LUAD.
Authors
- Yan Ding (ORCID: https://orcid.org/0000-0003-3119-9529)
- Ying Wang
Institutions
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1186/s40001-025-03559-3
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00